Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 2296 of 3330
Next
>>
>
57376 to 57400 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	0.000171	uM	12509.147	1.0697	1.1149	1.2058
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	0.000853	uM	12509.147	0.9863	0.9773	1.2058
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	0.00427	uM	12509.147	1.0468	1.0773	1.2058
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	0.0213	uM	12509.147	1.0388	1.0641	1.2058
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	0.107	uM	12509.147	0.9453	0.9088	1.2058
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	0.533	uM	12509.147	0.8504	0.7485	1.2058
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	2.67	uM	12509.147	0.5748	0.2636	1.2058
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	13.3	uM	12509.147	0.0497	-0.8340	1.2058
184A1	NM	Basal	Oxamflatin	HDAC	HDAC	66.7	uM	12509.147	0.0108	-0.9533	1.2058
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	0.000171	uM	12566.147	1.0521	1.0638	1.6169
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	0.000853	uM	12566.147	0.9434	0.9292	1.6169
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	0.00427	uM	12566.147	1.0004	1.0005	1.6169
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	0.0213	uM	12566.147	0.9234	0.9038	1.6169
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	0.107	uM	12566.147	0.9128	0.8902	1.6169
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	0.533	uM	12566.147	0.6918	0.5924	1.6169
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	2.67	uM	12566.147	0.4930	0.2915	1.6169
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	13.3	uM	12566.147	0.0420	-0.7183	1.6169
184B5	NM	Basal	Oxamflatin	HDAC	HDAC	66.7	uM	12566.147	0.0140	-0.8575	1.6169
600MPE	HR+	Luminal	Oxamflatin	HDAC	HDAC	0.000171	uM	12224.147	0.9944	0.9869	0.8621
600MPE	HR+	Luminal	Oxamflatin	HDAC	HDAC	0.000853	uM	12224.147	0.9733	0.9381	0.8621
600MPE	HR+	Luminal	Oxamflatin	HDAC	HDAC	0.00427	uM	12224.147	1.0297	1.0691	0.8621
600MPE	HR+	Luminal	Oxamflatin	HDAC	HDAC	0.0213	uM	12224.147	0.9545	0.8949	0.8621
600MPE	HR+	Luminal	Oxamflatin	HDAC	HDAC	0.107	uM	12224.147	0.9947	0.9876	0.8621
600MPE	HR+	Luminal	Oxamflatin	HDAC	HDAC	0.533	uM	12224.147	0.9162	0.8070	0.8621
600MPE	HR+	Luminal	Oxamflatin	HDAC	HDAC	2.67	uM	12224.147	0.7868	0.5145	0.8621

|<
<<
Previous
Page 2296 of 3330
Next
>>
>
57376 to 57400 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)